CD274 and nasopharyngeal carcinoma: Therefore, to gain a comprehensive overview of current clinical research progression on anti-PD-1/PD-L1 therapies for NPC, the study intends to undertake a thorough analysis of trials registered on ClinicalTrials.gov.